Clinically, this lesion can be misdiagnosed as mucocele, hemangioma, Kaposi sarcoma, angiosarcoma, pyogenic granuloma, and several other lesions. In this article, we report a case of intravascular papillary endothelial hyperplasia of the hypopharynx and larynx, which caused dysphagia inan lB-year-oldfemale patient.Thelesion was excised entirely via a lateral pharyngotomy approach. We discuss theclinicalandhistopathologicfeatures, differential diagnosis, and treatment of this uncommon entity.
Introduction
In 1923,Masson first described a benign i ntravasc~l ar lesion consisting ofintravascular papillaryhyperplasia and secondary thrombosis. 1 He introduced the term vegetant intravascular hemangioendothelioma, but intravascular angiomatosis, intravenous pyogenic granuloma, Masson disease,intravenouspapillary endothelial hyperplasia, and intravenous vascularproliferation are the other synonyms used to describe this lesion.
Clinically, intravascular papillary endothelial hyperplasia (IPEH) often presents as a subcutaneous or submucous red-blue mass. Skin lesions are mostly encountered in the head and neck region. The diagnosis might be controversial, and IPEH can be mistaken for mucocele, hemangioma, Kaposi sarcoma,angiosarcoma, pyogenic granuloma, and several other lesions . Recurrence after total excision is extremely rare.'
Case report
An 18-year-old female patient came to our institution with a complaint of dysphagia of 11/2 months' duration. Her medical history was unremarkable. On physical examination, her oropharynx was found to be normal. A reddish-blue mass, vascular in appearance, involving the right pyriform sinus and aryepiglottic fold, and protruding into the laryngeal ventricle was detected on endoscopic examination. Magnetic resonance imaging (MRI) showed a vascular mass obliterating the right pyriform sinus (figure 1) and extending to the laryngeal ventricle (figure 2). The mass was removed in its entirety via a lateral pharyngotomyapproach.The patient's postoperative course was without complication, and she was discharged 5 days after the operation. Histopathologic examination of the mass revealed IPEH (figure 3). Two weeks after surgery, her dysphagia had resolved .
Discussion
IPEH is a relatively rare lesion th at occurs in the fingers, head and neck , trunk, lower extremities, and upper extremities, in order of decreasing frequency.' IPEH also may involve the pharynx, buccal mucosa, lips, mouth, tongue, masseter muscle, and parotid gland.2.4 Although the larynx and hypopharynx are rarely affected,extravascular papillary endothelial hyperplasia of the larynx has been reported.' The average age of affected patients is stated to be 40 years, but the age distribution can vary from 9 months to 80 years ." Although a slight female preponderance has been reported, both sexes are almost equally affected.v' Three forms of IPEH have been described. A pure, or primary, form arises within dilated vascular space; a mixed, or secondary, form occurs within a preexisting vascular lesion, such as a hemangioma or pyogenic granuloma; and a rare, extravascular form arises in a hematoma." Development of a true neoplasm with sec- but they can be differentiated by their more columnar endothelial cellsand their lymphatic component. Mucoceles may resemb le IPEH clinicallywhen they present as a bluish raised mass on the lower lip, floor of the mouth, or tongue. However, these lesions are easilydistingui shed microscopically, as th ey are seen as a cavity consisting of fibrou s connective tissue and fibroblasts, and containing eosinophilic coagulum.
In conclusion, IPEH may clinically and radio logically ondary thrombosis, a reactive process possibly due to trauma, or an unusual thrornbusorganization have been suggested for the pat hogenesis of IPEH. 2 The differential diag nosis is important because IPEH can be mistaken for several other lesions. Clin ically, IPEH can be misdiagnosed as a mucocele, hemangioma, pyogenic granuloma, Kaposi sarcoma, angiosarcoma,Kimura disease, intravenous atypical vascular proliferation, endovascular papillary angioe ndothelioma, papular angioplasia, or bacillary angioma tosis.P " Radiologically, IPEH is contrast-enhancing and homog eno us on computed tomography (CT) or MRI and might con tain microcalcification areas. Hemangiomas, hematomas, or tumors may also contain microcalcification areas , On angiography, IPEH can manifest as a vascular or avascular ma ss.' Thus, there are no specific findings for IPEH on CT, MRI, or angiography.
Histopathologic examination is the mainstay of differential diagnosis. Histologically, bundles of papillae with single or several stalks presenting in a dilated vascular space, projecting and even occluding the lumen, are the main features of IPEH. 1 Angiosarcoma is differentiated by its invasive pattern, increased mitotic activity, necrotic foci, and cellular pleomorphism. The pyogenic granuloma is mostly found on the gingiva , but it also can affect the lips, buccal mucosa, and tongue. This lesion is characterized by a pedunculated mass with a smooth, verrucous surface and may become hemorrhagic. Endothelial cells are prominent features in both pyogenic granuloma and IPEH, but in the latter no surrounding vascular wall is evident.
Clinically, Kaposi sarcoma can be detected in the oral cavity, palate, or tongue as a reddish-brown or blue, flat, vascular lesion, and it may mimic IPEH. Histopathologically, characteristic features of Kaposi sarcoma include anastomosing slit-likevesselswith a fascicular pattern of spindle -shaped cells,capillary pro liferation, hemosiderin pigment deposition, and plasma-cell infiltration.
Hemangiomas can be differentiated from IPEH by their lack of endothelial proliferation un less th ey are secondarily tra umatized. Endovascular papillary angioendotheliomas are histologically similar to IPEH, Volume 87, Number 12 www.en tjourn al.com · 70 1 MATRKA, STEWARD, FALCIGLlA, NIKIFOROV iopanoic acid therapy, which likewise showed that FT 4 levels fell more slowly than FT 3Ievels. 6 ,7 The continued rise of both the FT 3 and FT 4 levels before the start of iopanoic acid therapy in the setting of thionamide treatment that we observed is also consistent with the mechanism of type II AlT. Because iodine uptake is low in this type of AIT, targeting the organification process with a thionamide would not be expected to have a significant effect.
Finally, the clinical findings of improved symptomatology are consistent with the rapid drop in FT 3 level and the delayed fall in FT 4levels. In a study comparing prednisone with iopanoic acid for type II AIT, Bogazzi et al found that a fall in FT 3 levels correlated with a resolution of symptoms, notwithstanding the persistent elevation of Fl'j levels."
For the long-term management oftype IIAIT,iopanoic acid remains inferior to corticosteroids." The use of iopanoic acid in this setting is limited by recurrence issues, by questions about the implications of clinically silent elevations in FT 4 levels, and by the unhindered progress of thyroid inflammation. Its preoperative use as described here, however, has engendered little opposition. The drug rapidly decreases FT3 levels without major risks, and at least in this case, the dose reduction alleviated side effects without diminishing the drug's efficacy. mimic several other lesions. Histopathologic examination is required to confirm the diagnosis. When IPEH is located in the supraglottic larynx and hypopharynx, as in our patient, the initial symptom might be dysphagia. The treatment of choice for this benign lesion is surgical removal. Recurrence is extremely rare.
